These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 29890303)

  • 21. Experimental strategies towards treating mitochondrial DNA disorders.
    Gardner JL; Craven L; Turnbull DM; Taylor RW
    Biosci Rep; 2007 Jun; 27(1-3):139-50. PubMed ID: 17492502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic potential of engineering the mitochondrial genome.
    Liu M; Ji W; Zhao X; Liu X; Hu JF; Cui J
    Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166804. PubMed ID: 37429560
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo mitochondrial base editing via adeno-associated viral delivery to mouse post-mitotic tissue.
    Silva-Pinheiro P; Nash PA; Van Haute L; Mutti CD; Turner K; Minczuk M
    Nat Commun; 2022 Feb; 13(1):750. PubMed ID: 35136065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene therapy by mitochondrial transfer.
    Kagawa Y; Inoki Y; Endo H
    Adv Drug Deliv Rev; 2001 Jul; 49(1-2):107-19. PubMed ID: 11377806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene therapy for the treatment of mitochondrial DNA disorders.
    Taylor RW
    Expert Opin Biol Ther; 2005 Feb; 5(2):183-94. PubMed ID: 15757380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial Transplantation in Mitochondrial Medicine: Current Challenges and Future Perspectives.
    D'Amato M; Morra F; Di Meo I; Tiranti V
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective elimination of mutant mitochondrial genomes as therapeutic strategy for the treatment of NARP and MILS syndromes.
    Alexeyev MF; Venediktova N; Pastukh V; Shokolenko I; Bonilla G; Wilson GL
    Gene Ther; 2008 Apr; 15(7):516-23. PubMed ID: 18256697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondrial Diseases: Hope for the Future.
    Russell OM; Gorman GS; Lightowlers RN; Turnbull DM
    Cell; 2020 Apr; 181(1):168-188. PubMed ID: 32220313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Read-through therapy for mitochondrial DNA nonsense mutations.
    Pacheu-Grau D; Gómez-Durán A; López-Gallardo E; Montoya J; Ruiz-Pesini E
    Drug Discov Today; 2012 Oct; 17(19-20):1063-7. PubMed ID: 22569067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in mitochondrial DNA and approaches for their correction.
    Patrushev MV; Kamenski PA; Mazunin IO
    Biochemistry (Mosc); 2014 Nov; 79(11):1151-60. PubMed ID: 25540000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heteroplasmy Shifting as Therapy for Mitochondrial Disorders.
    Naeem MM; Sondheimer N
    Adv Exp Med Biol; 2019; 1158():257-267. PubMed ID: 31452145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nuclear genes involved in mitochondrial diseases caused by instability of mitochondrial DNA.
    Rusecka J; Kaliszewska M; Bartnik E; Tońska K
    J Appl Genet; 2018 Feb; 59(1):43-57. PubMed ID: 29344903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-vitro genetic modification of mitochondrial function.
    Taylor RW; Chinnery PF; Turnbull DM; Lightowlers RN
    Hum Reprod; 2000 Jul; 15 Suppl 2():79-85. PubMed ID: 11041515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comprehensive molecular diagnosis of mitochondrial disorders: qualitative and quantitative approach.
    Wong LJ
    Ann N Y Acad Sci; 2004 Apr; 1011():246-58. PubMed ID: 15126301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid directional shift of mitochondrial DNA heteroplasmy in animal tissues by a mitochondrially targeted restriction endonuclease.
    Bayona-Bafaluy MP; Blits B; Battersby BJ; Shoubridge EA; Moraes CT
    Proc Natl Acad Sci U S A; 2005 Oct; 102(40):14392-7. PubMed ID: 16179392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Principles of and strategies for germline gene therapy.
    Wolf DP; Mitalipov PA; Mitalipov SM
    Nat Med; 2019 Jun; 25(6):890-897. PubMed ID: 31160821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondrial diseases: therapeutic approaches.
    DiMauro S; Mancuso M
    Biosci Rep; 2007 Jun; 27(1-3):125-37. PubMed ID: 17486439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of chemically modified oligonucleotides targeting a pathogenic mutation in human mitochondrial DNA.
    Tonin Y; Heckel AM; Dovydenko I; Meschaninova M; Comte C; Venyaminova A; Pyshnyi D; Tarassov I; Entelis N
    Biochimie; 2014 May; 100():192-9. PubMed ID: 23994754
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial diseases.
    Gorman GS; Chinnery PF; DiMauro S; Hirano M; Koga Y; McFarland R; Suomalainen A; Thorburn DR; Zeviani M; Turnbull DM
    Nat Rev Dis Primers; 2016 Oct; 2():16080. PubMed ID: 27775730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential of mitochondrial genome engineering.
    Silva-Pinheiro P; Minczuk M
    Nat Rev Genet; 2022 Apr; 23(4):199-214. PubMed ID: 34857922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.